Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml) for gonorrhea

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Jun 2026: Trial registered, NCT07631364

The trials

NCT07631364: Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections

State
Not started
Phase
Phase 3
People
360 planned
Started
Sep 2026
Primary completion
Oct 2028
Arms
A single 2 g dose of IV temocillin.
Results
None posted
  1. 8 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.